Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christophe Weber Insider Profile
4 Followers
Christophe Weber, Divisional President at GlaxoSmithKline, holds ― shares in GlaxoSmithKline (Ticker: GB:GSK).
Christophe Weber has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Christophe Weber does not currently own shares as a corporate insider.
A breakdown of Christophe Weber's holdings
Insider Roles
Divisional President
Roles that Christophe Weber holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christophe Weber
Christophe Weber's Trading History
List of latest transactions for each holding click on a transaction to see Christophe Weber's performance on stock
You May Also Like
Christophe Weber insider profile FAQ
What is the percentage of profitable transactions made by Christophe Weber?
The percentage of profitable transactions made by Christophe Weber is ―.
What is the average return per transaction made by Christophe Weber?
The average return per transaction made by Christophe Weber is ―.
What stocks does Christophe Weber hold?
Christophe Weber holds: GB:GSK stocks.
What was Christophe Weber’s latest transaction?
Christophe Weber latest transaction was an Uninformative Sell of 1.67M.
What was Christophe Weber's most profitable transaction?
Christophe Weber’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christophe Weber's role in GlaxoSmithKline?
Christophe Weber's role in GlaxoSmithKline is Divisional President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.